Clinical Trials Arena July 22, 2024
Experts say building strong outsourcing, site, agency, and sponsor relationships is the foundation of smooth clinical trial operations.
In an evolving drug development landscape, the pace and direction of progress depends on sponsors, outsourcing partners, and investors establishing strong foundational relationships.
Experts shared this sentiment at the 13th Annual Clinical Trials in Oncology East Coast 2024 conference, held on 9 – 10 July in Burlington, Massachusetts, while outlining the operational roles that each party must play to usher drug development down the right path.
Strong outsourcing relationships
The study of promising therapies begins at the site, and efficient and successful site performance ultimately relies on thorough feasibility processes, said Dr. Claudia Hesselmann, founder and CEO of the German early phase...